Healthcare & Life Sciences
FEMSelect
United Statesfemselect.com/
FEMSelect is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.
Activeseries-b
series-b
Stage
1
Investors
About FEMSelect
FEMSelect is a company headquartered in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
FEMSelect develops EnPlace, an FDA-cleared, minimally invasive medical device and procedure for same-day treatment of pelvic organ prolapse, aimed at restoring pelvic support without an overnight hospital stay.
Explore FEMSelect's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.